|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Series D Preferred Stock, par value $0.001 per share | $ 1 | 09/07/2017 | P | 97,850 | 09/07/2017 | (2) | Common Stock | 978,500 | (2) | 181,598 (3) | D | ||||
| Warrants to Purchase Common Stock | $ 1.44 | 09/07/2017 | P | 1,467,750 | 03/08/2018 | 09/07/2022 | Common Stock | 1,467,750 | (2) | 181,598 (3) | D | ||||
| Series E Preferred Stock, par value $0.001 per share | $ 1 | 10/17/2017 | P | 110,000 | 09/07/2017 | (4) | Common Stock | 1,100,000 | (4) | 181,598 (3) (5) | D | ||||
| Warrants to Purchase Common Stock | $ 1.2 | 10/17/2017 | P | 1,650,000 | 04/18/2018 | 10/17/2022 | Common Stock | 1,650,000 | (4) | 181,598 (3) (5) | D | ||||
| Series E Preferred Stock, par value $0.001 per share | $ 1 | 11/17/2017 | P | 40,000 | 01/10/2018 | (4) | Common Stock | 400,000 | (4) | 181,598 (3) (5) | D | ||||
| Warrants to Purchase Common Stock | $ 1.2 | 11/17/2017 | P | 600,000 | 05/18/2018 | 11/17/2022 | Common Stock | 600,000 | (4) | 181,598 (3) (5) | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| Struve Clayton A 175 W JACKSON BLVD SUITE 440 CHICAGO, IL 60604 |
X | |||
| clayton a struve | 04/09/2018 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | 1. As of July 27, 2017, 20,389 shares of were issued as dividends for the shares of Series C Preferred Stock owned by the Reporting Person, earned prior to the date of the automatic conversion of all shares of Series C Preferred Stock. |
| (2) | As of September 7, 2017, in connection with the Issuer's private placement offering, the Reporting Person purchased an aggregate of 97,850 Units at a price of $10.00 per Unit, with each Unit consisting of one share of the Company's Series D Preferred Stock, three shares of the Issuer's Common Stock and 15 Warrants to purchase the Issuer's Common Stock with an exercise price of $1.44 per share exercisable beginning 6 months after the date of issuance and within 5 years from the date of issuance. Each share of Series D Preferred Stock has a stated value of $10.00 and can be converted into shares of the Issuer's Common Stock at the price of $1.00 per share of Common Stock. Additional shares of Common Stock were issued at closing as dividends for the first year, issued in advance, at the rate of 8% per annum, based on a share price of $1.30. There is no expiration date for conversion of the Series D Preferred Stock. |
| (3) | . Does not include 978,500 shares of common stock into which such stockholder's shares of Series D Preferred are convertible, because such conversion is restricted pursuant to the terms of the Series D Preferred designations, which prohibit conversions that would result in the holder owning greater than 4.99% of the Company's issued and outstanding common stock, unless waived upon 60 days' notice, but shall in no event exceed 19.99%, of the Company's issued and outstanding common stock. Does not include 1,467,500 shares of common stock issuable upon such stockholder's exercise of warrants, because such issuance is restricted pursuant to the terms such warrants, which prohibit conversions that would result in the holder owning greater than 4.99% of the Company's issued and outstanding common stock, unless waived upon 60 days' notice, but shall in no event exceed 19.99%, of the Company's issued and outstanding common stock. Such warrants are exercisable beginning March 8, 2018. |
| (4) | Between October 17, 2017 and November 17, 2017, in connection with the Company's private placement offering, the Reporting Person purchased an aggregate of 150,000 Units at a price of $10.00 per Unit, each Unit consisting of one share of the Company's Series E Convertible Preferred Stock and 15 Warrants to purchase the Company's Common Stock with an exercise price of $1.20 per share exercisable beginning 6 months after the date of issuance and within 5 years from the date of issuance. Additional shares of Common Stock were issued on January 10, 2018, upon effectiveness of approval of the Company's shareholders, as dividends for the first year, issued in advance, at the rate of 20% per annum, based on a share price of $1.00. There is no expiration date for conversion of the Series E Preferred Stock. |
| (5) | Does not include 1,500,000 shares of common stock into which such stockholder's shares of Series E Preferred are convertible, because the Series E Preferred prohibits conversions that would result in the holder owning greater than 4.99% of the Company's issued and outstanding common stock, unless waived upon 60 days' notice, but shall in no event exceed 19.99%, of the Company's issued and outstanding common stock. Does not include 2,250,000 shares of common stock issuable upon such stockholder's exercise of warrants, because such warrants prohibit exercises that would result in the holder owning greater than 4.99% of the Company's issued and outstanding common stock, unless waived upon 60 days' notice, but shall in no event exceed 19.99%, of the Company's issued and outstanding common stock. 1,650,000 of such warrants are exercisable beginning April 18, 2018; 600,000 of such warrants are exercisable beginning May 18, 2018. |